Study Stopped
There was more benefit from the infusion arm compared to the bolus arm.
Dextrose Infusion by Burettes Versus Dextrose Boluses in Prevention of Neonatal Hypoglycemia
Dextrose Boluses Versus Dextrose Infusions by Burettes in Prevention of Hypoglycemia Among Preterms Admitted at Mulago Hospital: An Open Label Randomized Clinical Trial
1 other identifier
interventional
140
1 country
1
Brief Summary
NULL HYPOTHESIS • There is no difference in the incidence of hypoglycemia among preterms receiving either two hourly 10% dextrose boluses or 10% dextrose infusion by burettes during the 72 hours of admission in Special Care Unit- Mulago Hospital. ALTERNATE HYPOTHESIS • Use of two hourly 10% dextrose boluses increases the incidence of hypoglycemia by 30% compared to 10% dextrose infusion by burettes among preterms admitted to Special Care Unit in the first 72 hours of admission.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2012
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2012
CompletedFirst Submitted
Initial submission to the registry
September 17, 2012
CompletedFirst Posted
Study publicly available on registry
September 20, 2012
CompletedSeptember 20, 2012
September 1, 2012
2 months
September 17, 2012
September 17, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence proportion of hypoglycemia
3months
Secondary Outcomes (1)
survival measured as a proportion
3months
Study Arms (2)
Bolus arm
PLACEBO COMPARATORtwo hourly dextrose boluses administered via an intravenous cannula
infusion
EXPERIMENTAL10% dextrose infusion by burettes
Interventions
Eligibility Criteria
You may qualify if:
- Preterms whose care givers/ mothers gave informed consent
- Preterms whose age was \< 24 hours of life
- Preterms with birth weight ≥1kg
- Preterms with random blood sugar ≥ 2.6 mmol/l at admission into SCU.
You may not qualify if:
- Absence of a biological mother or abandoned baby
- Presence of gross congenital abnormalities.
- Very sick (Apgar score ≤ 5 at 5 minutes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mulago Hospital
Kampala, Mulago, +256, Uganda
Related Publications (1)
Kutamba E, Lubega S, Mugalu J, Ouma J, Mupere E. Dextrose boluses versus burette dextrose infusions in prevention of hypoglycemia among preterms admitted at Mulago Hospital: an open label randomized clinical trial. Afr Health Sci. 2014 Sep;14(3):502-9. doi: 10.4314/ahs.v14i3.2.
PMID: 25352865DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Elizabeth Kutamba.R
Study Record Dates
First Submitted
September 17, 2012
First Posted
September 20, 2012
Study Start
February 1, 2012
Primary Completion
April 1, 2012
Study Completion
April 1, 2012
Last Updated
September 20, 2012
Record last verified: 2012-09